NFKB1 and Parkinson disease: MPTP can be converted into the toxic form of MPP+; the latter would activate NF‐κB in microglia and astrocytes, and then facilitate the release of pro‐inflammatory cytokines, promoting the PD progression with α‐Syn dysfunction.41, 45